Aggressiveness in systemic anticancer therapy at the end of life in an oncology center.

This study confirms the relatively frequent aggressiveness in cancer treatment at the EoL. Taking into consideration previously published data, it can be tentatively concluded that the use of SACT increased in the last month and the last week of life.